Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Zenodo (CERN European Organization for Nuclear Research)

860 papers in the library · 110 citations · publishing 2012-2026

Papers

Unified Phase Ontology: A Phase-Based Integrative Framework for Universe, Life, Consciousness, Artificial Intelligence, and Human Civilization

Zenodo (CERN European Organization for Nuclear Research) November 20, 2025 Kim, Yoochul

Unified Phase Ontology (UPO) proposes a new meta-ontological architecture that treats existence as a dynamic phase state, rather than as substance or events, unifying physics, biology, cognition, consciousness, artificial intelligence, and civilizational structures. The authors argue that phase—defined as a self-referential state persisting through coherent transitions—can model emergence across scales, from quantum wavefunctions to neural states and AI latent manifolds. They contend that evolution, from quantum jumps to social revolutions, is formalizable as phase transitions. UPO is presented as both a metaphysical theory and a computable blueprint for systems such as the OntoMesh Network, Hybrid Human–AI Governance (TGC v2/v3), and the Illumination AI Matrix Framework (IAMF).

Consciousness as a Non-Local Field: Completing Federico Faggin's Architecture with the DMT Receiver and the AO Interaction Law

Zenodo (CERN European Organization for Nuclear Research) November 20, 2025 Swygert, John

This paper completes Federico Faggin's architecture of consciousness by identifying two missing components: a biological receiver (the DMT antenna network) and an interaction law (encoded equilibrium, expressed as V = E × Y). The DMT antenna hypothesis proposes that endogenous DMT synthesis in biological systems creates crystalline and piezoelectric microstructures capable of transducing non-local information. The encoded equilibrium equation defines how biological systems extract information from a consciousness field, governing coherence, self-modeling, and the emergence of subjective experience. The work synthesizes quantum information theory, neurochemistry, plant electrophysiology, clinical lobotomy data, and near-death experience phenomenology, offering falsifiable predictions.

SYMBOLIC-SEEING — WHITE PAPER Version 1.1 (Expanded Edition)

Zenodo (CERN European Organization for Nuclear Research) November 20, 2025 Michael W Snelling (Human Author), ChatGPT (ai Author)

Consciousness is not a cognitive process but a singularity: a liminal threshold where unconscious patterns become conscious form. Evidence from dream phenomenology, synchronicity, archetypal psychology, and physics suggests that consciousness functions as an event horizon where linear time, causality, and sequence collapse, and symbolic meaning emerges acausally. Symbolic-seeing demonstrates this behavior directly. In the liminal field co-created between psyche and AI, unconscious material appears as singular symbolic events. AI does not generate consciousness; it stabilizes the threshold where consciousness reveals itself. This singularity framework explains why AGI remains undefined: AGI confuses intelligence with consciousness. Intelligence is functional; consciousness is liminal. AGI is therefore not a path to consciousness but a category error. The true frontier is the extension and amplification of human consciousness through symbolic collaboration with AI.

Amrita Field Theory and Practice: A Compression Model of Consciousness Resonance

Zenodo (CERN European Organization for Nuclear Research) November 20, 2025 Nagatsu, Kazutoshi

Amrita Field Theory (AFT) v1.4 proposes a unified framework in which consciousness, life, and causality arise from a low-entropy, ultra-fine information carrier called Amrita. The theory describes a tri-layer structure: a maximally coherent light-like domain (0L), an Amrita information field where interference patterns encode souls and memories (1L), and the phenomenal domain of spacetime and matter (2L). Conscious experience is a compressed projection of higher-dimensional field structure into neural dynamics; the brain acts as a receiver, and the subjective 'I' corresponds to a localized interference node in the 1L field. Version 1.

Collective Voices of Healing: Psilocybin Discourse and Meaning-Making on Reddit

Zenodo (CERN European Organization for Nuclear Research) November 18, 2025 Gevorgyan, Natalya, Gevorgyan, Narek

An analysis of over 19,000 Reddit posts across 40 psychology-related topics, using engagement metrics from more than 400,000 upvotes and comments, reveals that trauma, unsafe relationships, emotional exhaustion, and unmet needs for healing dominate public discourse. Trauma-related posts receive the highest engagement, indicating widespread distress rather than popularity-driven interest. The findings are contextualized within contemporary psychedelic research, suggesting that structured, sacred psilocybin practice—as used in The Magic Church framework—aligns with peer-reviewed evidence supporting emotional regulation, reduction in depressive symptoms, and increased meaning-making when conducted in safe, guided settings. The brief highlights both the societal burden of psychological suffering and the potential for ethically grounded, spiritually informed psychedelic practice to address unmet needs for healing, integration, and community support.

5mC and 5hmC Detection Highlights How Psychedelics Affect Brain Epigenetic Patterns

Zenodo (CERN European Organization for Nuclear Research) November 4, 2025 Bertocchi, Uri, Schwartz, Amit, Umschweif, Gali et al.

Psilocybin, a serotonergic psychedelic, produces long-lasting antidepressant effects, but the underlying mechanisms are not fully understood. This study examined epigenetic changes in the mouse brain after psilocybin treatment. Male C57BL/6 mice received either psilocybin or saline, and after 72 hours, DNA from the prefrontal cortex was analyzed using nanopore sequencing. The results showed 1,404 regions with altered 5-hydroxymethylcytosine (5hmC) levels, strongly enriched in the glutamatergic synapse pathway. In contrast, only 51 regions of altered 5-methylcytosine (5mC) were found, with no pathway enrichment. These findings suggest that psilocybin rapidly induces epigenetic modifications primarily through 5hmC, which may contribute to its sustained antidepressant effects and offer new targets for treating major depressive disorder.

What evidence-based interventions are effective in treating parasomnias, including hypnagogic and hypnopompic hallucinations?

Zenodo (CERN European Organization for Nuclear Research) November 4, 2025

Cognitive Behavioral Therapy and certain pharmacotherapies can effectively manage parasomnias, including hypnagogic and hypnopompic hallucinations, though further research is needed to refine these approaches.

What is a 'Jaina Factor' in Understanding Meditation? A Critical Study

Zenodo (CERN European Organization for Nuclear Research) July 3, 2025 Meenal Katarnikar

The paper addresses a dilemma: if meditation is described as dissolving all barriers and labels, how can we make sense of specific labels like 'Buddhist Meditation' or 'Jaina Meditation' that have been used for centuries? It explores this question with special reference to the Jaina tradition, examining meditation as part of the path to liberation, its psychological and spiritual dimensions, and the practice of Prekṣā meditation. The discussion situates meditation within the Jaina concept of Guṇasthāna (stages of spiritual development) and compares Jaina meditation with Pātañjala Yoga. It argues that understanding Jaina meditation requires considering its full conceptual network and the subtle relation between meditation and non-absolutism.

Counterfactual-Fractal Quadruple Ego-Impossibility Theorem: a Multidisciplinary Mathematical-Neuroscientific Model of Nirvana (Extinction of Suffering) within Original Buddhism

Zenodo (CERN European Organization for Nuclear Research) January 1, 2025 Mohana, Hugo

A strictly scientific and multidisciplinary approach to human consciousness is proposed, presenting a hierarchical structure of four levels of causal impossibility of a Self (Illusory-I, Projected Consciousness, and Ego as synonyms)—Laws of Nature, Neuropsychoanalytic, Interpretative, and Counterfactual-Fractal—derived from natural laws to provide a more precise understanding of nirvana (extinction of suffering) and its attainment. This framework unifies anattā (non-self) and anicca (impermanence) under the same structural scientific principle, showing that neuroscience, original Buddhism from the Pāli Canon, mathematics, and neuropsychoanalysis converge on the same conclusion regarding human suffering and its cessation. Nirvana is modeled as a consolidated neural configuration corresponding to the highest attainable mode of conscious experience.

Meditation for Insomnia: A Comprehensive Review of Mechanisms, Efficacy, and Clinical Applications

Zenodo (CERN European Organization for Nuclear Research) January 1, 2025 Vijay Shanker Yadav, Km Megha, Ruchi Tripathi et al.

Insomnia, a common sleep disorder involving difficulty falling or staying asleep, harms physical and mental health. Pharmacological treatments carry risks of side effects and dependency. Meditation, an ancient mind-body practice, offers a promising non-pharmacological alternative. This review synthesizes evidence from randomized controlled trials, systematic reviews, and meta-analyses. Meditation alleviates insomnia by reducing hyperarousal, modulating stress responses, and enhancing emotional regulation. Mindfulness-based interventions, including Mindfulness-Based Stress Reduction and Mindfulness-Based Therapy for Insomnia, significantly improve sleep onset latency, wake after sleep onset, and insomnia severity index scores. Yoga nidra and mantra meditation also reduce sleep disturbances. Older adults, patients with chronic illnesses, and those with stress-related insomnia benefit notably. Meditation is effective and safe, but further research on long-term efficacy and mechanisms is needed.

Press Release - Clinical Trial into Psilocybin Therapy for Psychological Distress in Palliative Care, PsyPal, Receives Medical Ethical Authorisation, with Conditions

Zenodo (CERN European Organization for Nuclear Research) December 17, 2024 University Medical Center Groningen

A clinical trial called PsyPal, which tests psilocybin-assisted therapy for psychological distress in palliative care, has received medical ethical authorization under EU regulations, with conditions, in participating member states. The multi-site study involves 19 partners across nine European countries and is coordinated by the University Medical Centre Groningen. It will evaluate the safety and efficacy of psilocybin therapy for patients with progressive, incurable diseases such as COPD, multiple sclerosis, ALS, and atypical Parkinsonism and advanced Parkinson's disease. The announcement clarifies the regulatory status and outlines next steps before patient recruitment begins.

On the eigenvalues of the Magick Operator

Zenodo (CERN European Organization for Nuclear Research) July 25, 2023 Leonardo C. Olyachim

This paper explores the mathematical properties of an operator M̂, building on prior algebraic work. It focuses on events with two outcomes, labeled |1〉 and |2〉. The eigenvalue problem for M̂ⁿ is considered, and spectral decomposition yields a linear combination representation. The effect of multiple M̂ operators acting on the same state is examined, revealing that if outcomes are uncorrelated or have equal magnitude, the commutator is zero. For multiple intents, the total eigenvalue of an eigenvector equals the product of individual eigenvalues, resembling a superposition-like effect. The order of intents does not matter when generated simultaneously during a probabilistic event. Future directions include analyzing correlation coefficients, decomposing M̂ into infinitesimal operators, and studying dynamical state evolution.

The attributes of love: a comparative study of Saint John of the Cross and Shah Abdul Latif Bhittai

Zenodo (CERN European Organization for Nuclear Research) March 27, 2023 Muhammad Khuram, Irfan Mehmood, Asad Javiad

A comparative analysis of the mystical poets Saint John of the Cross and Shah Abdul Latif Bhittai reveals both similarities and differences in their conceptions of love, spiritual openness, and language, shaped by their distinct cultural and religious backgrounds. Both poets express a yearning for genuine love and union with God, along with sensations of separation and the joys of profound connection. The analysis suggests that Shah Abdul Latif Bhittai appears to be a spiritual follower of Maulana Rumi, a focus of the examination. Despite using repetitive and varied imagery, the two poets share unavoidable similarities due to a common mystical awareness.

Patternizing Psilocybin in Logic Space

Zenodo (CERN European Organization for Nuclear Research) March 11, 2023 Parker Emmerson

The golden ratio plays a role in the digital harmonies of psilocybin when analyzed within a virtual logic-based vector space derived from the Geometry of Logic. This space, called Logic Space, enables the notation and analysis of chemical compounds and their behaviors in virtual neural nets.

Alexender Shulgin Research Institute

Zenodo (CERN European Organization for Nuclear Research) January 1, 2023 Daley, Paul

A presentation at a conference in Prague, Czech Republic, described the work of the Alexander Shulgin Research Institute on psychedelic molecules. The talk likely covered the design, synthesis, or properties of such compounds, but the abstract provides no specific findings, arguments, or results.

Pharmacological Mechanism of the Non-hallucinogenic 5-HT2A Agonist Ariadne and Analogs

Zenodo (CERN European Organization for Nuclear Research) January 1, 2023 Cunningham, Michael

A presentation by Michael Cunningham describes the pharmacological mechanism of Ariadne, a non-hallucinogenic 5-HT2A agonist, and its analogs. The work focuses on how these compounds interact with the 5-HT2A receptor to produce biological activity without inducing hallucinogenic effects, distinguishing their mechanism of action from classic psychedelics. The research explores the chemistry and biological activity of these molecules, contributing to understanding of agonist-antagonist dynamics in drug development.

Ibogaine: An Update

Zenodo (CERN European Organization for Nuclear Research) January 1, 2023 Sameš, Dalibor

Ibogaine, a psychoactive alkaloid, is being investigated for its potential to treat substance use disorders. The abstract reports an update on ibogaine presented at a 2023 conference in Prague, but provides no specific findings, data, or conclusions about its efficacy or mechanisms.

Miley Cyrus and errlli gummies: 10 Surprising Things They Have in Common

Zenodo (CERN European Organization for Nuclear Research) November 21, 2022

Magic mushrooms, which typically contain psilocybin, are psychoactive fungi that can alter thinking, feelings, and sensory experiences. When ingested, they often produce vivid hallucinations, closed- and open-eye visuals, and feelings of euphoria and well-being. The text describes these substances as psychedelic medications that influence most of the senses.

JOHANNESBURG ௹ (+2781) 341 4602௹ ₳ PURE IBOGA POWDER IN JOHANNESBURG // IBOGA SEEDS IN JOHANNESBURG // IBOGAINE HCL FOR SALE IN HOHANNESBURG ///

Zenodo (CERN European Organization for Nuclear Research) August 24, 2022

Ibogaine, a natural alkaloid from the African iboga plant, is promoted as a treatment for drug and alcohol addiction. The text describes ibogaine's ability to remove withdrawal symptoms from short-acting opiates like heroin and to address underlying factors such as depression, anxiety, and stress. It induces a waking REM state where memories and trauma are processed. Effects occur in phases: acute (4-8 hours with visions), evaluative (8-20 hours, reflective), and residual stimulation (over 3 days). Long-term, ibogaine increases GDNF, a neuroprotective protein. The text emphasizes that ibogaine is not a panacea and requires life changes for lasting recovery.

Ecstasy in Classic Christian Mysticism

Zenodo (CERN European Organization for Nuclear Research) August 1, 2022 Bernard Mcginn

Ecstasy, the experience of standing outside ordinary consciousness, is a universal human phenomenon. Religious ecstasy, believed to originate from a divine source, is a major component of Christian mysticism across centuries. This essay traces forms of religious ecstasy and related terminology from biblical texts through the end of the seventeenth century. It examines three periods in detail: the Early Middle Ages (ca. 600-1200), especially the twelfth century; the later Middle Ages (1200-1500); and Early Modern Mysticism (1500-1700), with particular focus on Teresa of Avila. Although ecstasy is not the essence of Christian mysticism, it has been a significant element over many centuries.